GLP-1s in Medicare and Medicaid: Access alone is not a care model
(Pankhuri Sharma, Humana for Becker’s Hospital Review) The clinical value of GLP-1 receptor agonists is now well established. Multiple trials
Read More(Pankhuri Sharma, Humana for Becker’s Hospital Review) The clinical value of GLP-1 receptor agonists is now well established. Multiple trials
Read MoreOn November 14, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the Part B premiums for 2026. The
Read More(Authors: Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Juliette Cubanski, and Tricia Neuman for The Kaiser Family Foundation Published: May
Read More(Authors: Nancy Ochieng, Meredith Freed, Juliette Cubanski, Jeannie Fuglesten Biniek, and Tricia Neuman for The Kaiser Family Foundation Published: May
Read MoreThe Income-Related Monthly Adjustment Amount (IRMAA) is not a penalty, but rather a pricing structure. IRMAA was created under the
Read More(Authors: Maiss Mohamed, Alice Burns, and Jeannie Fuglesten Biniek for The Kaiser Family Foundation Published: May 14, 2026) On May
Read MoreTo simplify access to the Medicare Savings Programs (MSPS), the Aging & Disability Health Policy Lab has drafted four model
Read More(By: Naomi Diaz for Becker’s Hospital Review) The Centers for Medicare & Medicaid Services is imposing a six-month nationwide moratorium
Read More(Authors: Meredith Freed, Juliette Cubanski, and Elizabeth Williams for The Kaiser Family Foundation Published: May 11, 2026) GLP-1s, a class
Read More(By Rachel Spears for KFF Health News) Next time you go to the pharmacy, you might be offered a coupon
Read More